Key Takeaways
- Nattokinase is a fibrinolytic enzyme from natto (fermented soybeans) that directly breaks down fibrin in blood clots — one of the few dietary supplements with this mechanism, supported by decades of biochemical research
- A meta-analysis of 6 randomized controlled trials (546 participants) found nattokinase significantly reduced systolic blood pressure by 3.45 mmHg and diastolic by 2.32 mmHg — modest but clinically meaningful
- Standard clinical dosage is 2,000-4,000 FU (fibrinolytic units) per day, with the Japan Nattokinase Association (JNKA) recommending a minimum of 2,000 FU daily
- Nattokinase interacts with blood-thinning medications including warfarin and aspirin — medical consultation is essential before use if you take anticoagulants
- Japanese quality standards for nattokinase, particularly NSK-SD certification, ensure vitamin K2 removal and standardized enzyme activity — a level of quality assurance with no direct international equivalent
You have probably seen nattokinase mentioned in a health article, a supplement store, or a social media post about "natural blood thinners." The claims range from dissolving blood clots to lowering blood pressure to protecting your brain — and it can be hard to separate the evidence from the hype.
Here is what makes nattokinase genuinely interesting: it is one of the few dietary supplements with direct fibrinolytic activity, meaning it can actually break down fibrin, the protein that forms the structural mesh of blood clots. That is a rare and specific mechanism, and clinical trials have tested it. But the evidence is not equally strong for every claim you will encounter online.
We reviewed the clinical research on nattokinase — including meta-analyses, randomized controlled trials, and Japanese studies that rarely appear in English-language guides — to give you a clear picture of what this enzyme does, where the science is solid, and where it is still developing. Whether you are considering nattokinase for cardiovascular support or just trying to understand what it is, this guide covers the evidence, the safety considerations, and the practical details you need to make an informed decision.
What Is Nattokinase?
Nattokinase is a serine protease enzyme extracted from natto, a traditional Japanese fermented soybean food that has been consumed in Japan for centuries. The enzyme was discovered in 1980 by Dr. Hiroyuki Sumi at Kurashiki University of Science and the Arts, when he observed that natto could dissolve artificial fibrin clots in a laboratory setting [1].
The enzyme is produced by Bacillus subtilis var. natto during the soybean fermentation process. Despite its name, nattokinase is not actually a kinase — it was named before its enzymatic mechanism was fully characterized. It is classified as a subtilisin-like serine protease with a molecular weight of approximately 27.7 kDa [1].
What makes nattokinase unusual among dietary supplements is its direct biological activity: it can break down fibrin, the protein mesh that holds blood clots together. This fibrinolytic property is what has driven decades of clinical research into its cardiovascular applications.
Nattokinase Supplements vs Eating Natto
If nattokinase comes from natto, why not just eat natto? There are several important differences to understand.
Vitamin K2 content is the most significant distinction. Whole natto is one of the richest dietary sources of vitamin K2 (menaquinone-7), which promotes blood coagulation — the opposite effect of nattokinase's clot-dissolving action. For people taking blood-thinning medications like warfarin, the vitamin K2 in natto can reduce the drug's effectiveness [13]. Nattokinase supplements with NSK-SD certification have the vitamin K2 removed, making them suitable for anticoagulant users [19].
Standardized dosing is another practical advantage. Supplements provide a measured amount of enzyme activity in fibrinolytic units (FU), while the nattokinase content of natto food varies by preparation method and fermentation conditions [3].
Finally, natto has a strong, distinctive flavor and sticky texture that many people — including many Japanese people — find challenging. Supplements bypass this barrier entirely.
One gap worth noting: no head-to-head studies have directly compared the bioavailability of nattokinase from supplements versus natto food. The assumption that supplements deliver equivalent or better absorption is reasonable but not definitively proven.
How Nattokinase Works
The Fibrinolytic Mechanism
Nattokinase acts through multiple pathways to break down blood clots, which is what makes it distinctive among dietary supplements [1][2]:
- Direct fibrinolysis: Nattokinase directly hydrolyzes fibrin — the protein mesh that forms the structural backbone of blood clots — into soluble degradation products. This direct action is rare among oral supplements.
- Indirect plasminogen activation: The enzyme converts pro-urokinase to urokinase, which activates plasminogen into plasmin — the body's primary endogenous clot-dissolving enzyme. This effectively amplifies the body's own fibrinolytic capacity.
- PAI-1 degradation: Nattokinase degrades plasminogen activator inhibitor-1 (PAI-1), a protein that normally inhibits fibrinolysis. By removing this natural brake, clot breakdown is further enhanced.
- Platelet aggregation inhibition: At standard doses, nattokinase inhibits platelet aggregation without significantly affecting prothrombin time (PT) or activated partial thromboplastin time (aPTT) [1].
How does this compare to pharmaceutical blood thinners? Nattokinase offers oral bioavailability and a longer biological half-life (up to 8-12 hours) compared to many pharmaceutical agents. However, it lacks the potency of intravenous thrombolytics like tissue plasminogen activator (tPA). The safety margin for hemorrhagic adverse effects is reported to be three times higher than tPA [6]. This is not a recommendation to substitute nattokinase for prescribed medications — the comparison illustrates the enzyme's pharmacological profile.
Beyond Blood Clots
Research has identified additional mechanisms beyond fibrinolysis. Nattokinase demonstrates anti-inflammatory effects in animal models [7], and preclinical studies suggest it may influence lipid metabolism. These secondary mechanisms are less well-established than the fibrinolytic activity and should be considered supporting evidence rather than primary benefits.
Evidence-Based Benefits of Nattokinase
Blood Pressure Reduction: Strong Evidence
This is the most robustly supported benefit of nattokinase supplementation. A systematic review and meta-analysis of 6 randomized controlled trials involving 546 adults found statistically significant reductions in both systolic and diastolic blood pressure [2]:
- Systolic blood pressure: reduced by 3.45 mmHg (95% CI: -4.37 to -2.18, p<0.00001)
- Diastolic blood pressure: reduced by 2.32 mmHg (95% CI: -2.72 to -1.92, p<0.00001)
Two key trials anchor this evidence. A landmark randomized controlled trial of 86 Korean adults with pre-hypertension or stage 1 hypertension found that 2,000 FU per day of nattokinase for 8 weeks produced significant reductions in both systolic and diastolic blood pressure compared to placebo [4]. A multicenter North American trial confirmed these findings and also demonstrated reduced von Willebrand factor, a cardiovascular risk marker [5].
Important context: These reductions are modest — roughly 3-5 mmHg — which is clinically meaningful for population-level cardiovascular risk reduction but not a replacement for antihypertensive medication in people with diagnosed hypertension. Think of it as a supportive measure, not a primary treatment.
Blood Clot Prevention and Cardiovascular Health: Moderate Evidence
Nattokinase's fibrinolytic activity is well-established in laboratory settings, and several clinical studies have explored cardiovascular applications. However, the evidence here is more complex than for blood pressure.
The largest and most rigorous trial must be acknowledged honestly. The Nattokinase Atherothrombotic Prevention Study (NAPS) enrolled 265 individuals without clinical cardiovascular disease and randomized them to 2,000 FU per day of nattokinase or placebo for 3 years. The primary finding: no significant effect on subclinical atherosclerosis progression as measured by carotid artery intima-media thickness. However, the study did confirm long-term safety [8].
Other studies show more positive signals. An observational study of nattokinase in patients with vascular diseases found it slowed atherosclerosis progression and was well-tolerated [9]. A randomized trial of nattokinase combined with red yeast rice in patients with stable coronary artery disease demonstrated antithrombotic effects with no adverse events [10].
The bottom line: Nattokinase has clear fibrinolytic activity, and biomarker studies show positive changes. But the largest prevention trial found no effect on arterial changes, which tempers broader cardiovascular claims. Blood pressure benefits are better supported than atherosclerosis prevention.
Cholesterol and Lipid Effects: Emerging Evidence
Evidence for nattokinase's effects on cholesterol is mixed and should be interpreted cautiously.
The meta-analysis found that low total-dose nattokinase actually increased total cholesterol by 5.27 mg/dL — an unfavorable direction [2]. Individual studies using higher doses or combination formulations (nattokinase with red yeast rice) show lipid improvements [11], but the combination products make it difficult to attribute effects specifically to nattokinase.
A recent review summarized the conflicting evidence, noting that heterogeneity in doses and formulations across studies makes consensus difficult [12]. If cholesterol management is your primary goal, nattokinase is not well-supported for that purpose at this time.
Stroke Prevention: Emerging Evidence
Evidence for stroke prevention is primarily epidemiological and indirect. Population data from Japan suggests that communities with higher natto consumption have lower rates of cardiovascular mortality, including stroke [1]. One small trial in acute ischemic stroke patients showed oral nattokinase slowed stroke progression.
However, the NAPS trial — which measured a surrogate marker for stroke risk (carotid atherosclerosis) — showed no effect [8]. No randomized controlled trials have measured actual stroke events as a primary endpoint.
It is important to distinguish between observational data on natto consumption (a whole food with many active components) and interventional data on nattokinase supplementation (an isolated enzyme). The epidemiological associations are interesting but cannot be directly attributed to nattokinase alone.
Brain Health and Anti-Inflammatory Effects: Preliminary Evidence
Preclinical studies suggest nattokinase may degrade amyloid-beta fibrils, the protein aggregates associated with Alzheimer's disease [1]. The enzyme has also demonstrated anti-inflammatory properties in animal models [7].
These findings are entirely preclinical — no human clinical trials have tested nattokinase for brain health or inflammation-specific endpoints. They represent interesting directions for future research, not actionable health benefits at this stage.
Nattokinase Dosage and How to Take It
Clinical trial data and Japanese regulatory guidance provide a reasonably clear picture of appropriate dosing.
| Parameter | Recommendation | Source |
|---|---|---|
| Standard clinical dose | 2,000-4,000 FU per day | Multiple RCTs [2] |
| JNKA minimum recommendation | 2,000 FU per day | Japan Nattokinase Association [19] |
| MHLW reference range | 2,000-7,000 FU per day | Ministry of Health, Labour and Welfare (厚生労働省) [21] |
| Safety tested | 10 mg/kg/day for 28 days (human volunteers) | No adverse effects [6] |
What to Look for on Labels
Always check for FU (fibrinolytic units), not mg. Milligrams measure the weight of the powder, but FU measures actual enzyme activity — which is what matters for biological effect. A supplement with 100 mg of nattokinase could contain widely varying FU activity depending on the concentration and quality of the enzyme preparation [12].
NSK-SD certification from the Japan Nattokinase Association (JNKA) indicates that the product has been verified for vitamin K2 removal, stable fibrinolytic activity, and pharmaceutical-grade purity. This certification has no direct equivalent outside Japan [19].
Timing and Practical Guidance
No randomized controlled trials have specifically compared morning versus evening dosing. Some practitioners suggest taking nattokinase in the evening based on the rationale that fibrinolytic activity during overnight hours — when blood flow slows — may be beneficial. This is a reasonable hypothesis but not evidence-based guidance. A Japanese study in healthy subjects demonstrated enhanced fibrinolytic activity after a single oral dose, suggesting acute pharmacological effects regardless of timing [18].
If you are new to nattokinase, starting at 2,000 FU per day and monitoring for any digestive sensitivity before increasing is a reasonable approach.
How Long Until You See Results?
This is a question most guides skip, and the honest answer requires distinguishing between different outcomes.
| Outcome | Expected Timeline | Evidence Basis |
|---|---|---|
| Fibrinolytic activity | Hours (acute single-dose effect) | Japanese pharmacological study [18] |
| Blood pressure reduction | 4-8 weeks | Landmark RCT showed significant effects at 8 weeks [4] |
| Cardiovascular biomarkers | 4-12 weeks | Most clinical trials measure outcomes at this interval |
| Atherosclerosis prevention | Not demonstrated even at 3 years | NAPS trial [8] |
Important note: These timelines reflect when studies measured outcomes, not definitively when effects begin. No studies have been specifically designed to measure the time-to-onset of nattokinase's benefits. If you are taking nattokinase for blood pressure support, allow at least 8 weeks of consistent use before evaluating whether it is working for you.
Safety Considerations
Overall Safety Profile
Clinical trials report that nattokinase is generally well-tolerated with a low adverse event rate. Animal toxicity studies showed no adverse effects even at doses 1,000 times the typical human dose (480,000 FU/kg) [6]. However, nattokinase's mechanism of action — dissolving fibrin and inhibiting clotting — means that safety considerations around bleeding risk are inherently important.
Common Side Effects
- Gastrointestinal effects: Nausea, bloating, and diarrhea — generally mild and infrequent [13]
- Bruising or bleeding: Increased risk due to the fibrinolytic mechanism, particularly when combined with other blood thinners
- Allergic reactions: Possible in individuals with soy or natto sensitivity, ranging from urticaria to anaphylaxis in rare cases
- Blood glucose: The meta-analysis noted a very small, clinically insignificant increase of 0.40 mg/dL [2]
Serious Adverse Events (Case Reports)
While rare, serious events have been documented and are important to understand [13]:
- Internal bleeding leading to death in an elderly woman taking nattokinase for atrial fibrillation
- Vascular necrosis and arm amputation from intravascular injection of enzymatic supplements containing nattokinase
- A patient who substituted nattokinase for warfarin after mechanical aortic valve replacement — a thrombus formed on the valve, requiring repeat surgery
These cases highlight a critical point: nattokinase is not a substitute for prescribed anticoagulant medications, and self-substitution without medical supervision can have life-threatening consequences.
Drug Interactions
| Medication Class | Interaction Mechanism | Risk Level |
|---|---|---|
| Warfarin | Additive anticoagulant effect — both reduce clot formation through different mechanisms | HIGH — avoid without medical supervision |
| Aspirin | Additive antiplatelet and fibrinolytic effects | HIGH — increased bleeding risk |
| Other anticoagulants/antiplatelets (heparin, clopidogrel, ticagrelor) | Additive anticoagulant/antiplatelet effect | HIGH — avoid without medical supervision |
| NSAIDs (ibuprofen, naproxen) | Additive blood-thinning effects via COX-1 inhibition | MODERATE — monitor for bleeding signs |
| Antihypertensive drugs | Additive blood pressure lowering (nattokinase may reduce BP by 3-5 mmHg independently) | MODERATE — monitor blood pressure |
Who Should Avoid Nattokinase
- People with bleeding disorders or active bleeding conditions [13]
- People with deep vein thrombosis (DVT): Theoretical risk of dislodging existing clots, potentially causing embolism
- Anyone with upcoming surgery, including dental procedures: Discontinue 1-2 weeks before to prevent excessive bleeding
- People with soy allergies or natto sensitivity
- People with mechanical heart valves who rely on anticoagulant therapy
Pregnancy and Nursing
No specific safety data exists for pregnant or nursing populations. Given nattokinase's anticoagulant properties and the physiological changes in coagulation during pregnancy, the default recommendation is to avoid nattokinase without explicit healthcare provider guidance [13].
Realistic Expectations
Nattokinase is a dietary supplement with an interesting and well-characterized mechanism. It is not a cure for cardiovascular disease, not a replacement for prescribed blood thinners, and not a substitute for medical treatment of existing blood clots. Its strongest evidence supports a modest blood pressure reduction — meaningful as part of a broader cardiovascular health strategy, but not a standalone solution.
Nattokinase vs Other Fibrinolytic Enzymes
If you are researching nattokinase, you may have encountered other enzyme supplements with fibrinolytic or anti-inflammatory properties. No head-to-head clinical trials compare these enzymes directly, but here is how they differ based on their individual evidence bases [1][17]02699-9):
| Feature | Nattokinase | Serrapeptase | Lumbrokinase | Bromelain |
|---|---|---|---|---|
| Source | Fermented soybeans (natto) | Silkworm intestinal bacteria | Earthworms | Pineapple stems |
| Primary mechanism | Direct fibrinolysis + plasminogen activation | Anti-inflammatory, mucolytic, some fibrinolytic activity | Direct fibrinolysis (potentially stronger per unit) | Anti-inflammatory, antiplatelet, mild fibrinolytic |
| Best evidence for | Blood pressure, fibrinolysis | Pain and inflammation, sinusitis | Deep vein thrombosis, fibrinolysis | Inflammation, joint pain, sinusitis |
| Clinical evidence level | Strongest — multiple RCTs, meta-analysis available | Moderate — some RCTs, mostly for inflammation | Limited — fewer human studies | Moderate — several RCTs for inflammation |
| Typical dosage | 2,000-4,000 FU/day | 10-60 mg/day (120,000-240,000 SPU) | 20-40 mg/day (600,000 IU) | 500-1,000 mg/day (GDU varies) |
| Safety profile | Well-tolerated; bleeding risk with anticoagulants | Generally well-tolerated; some GI effects | Less safety data available | Well-tolerated; GI effects, allergic reactions |
| Unique advantage | Oral bioavailability, long half-life, dual-pathway mechanism | Anti-inflammatory without NSAIDs | Potentially stronger fibrinolytic activity per dose | Anti-inflammatory + digestive enzyme benefits |
Key takeaway: Nattokinase has the strongest overall clinical evidence base among fibrinolytic enzyme supplements, particularly for cardiovascular applications. Serrapeptase and bromelain are better supported for anti-inflammatory use. Lumbrokinase may have stronger fibrinolytic potency per dose but lacks the volume of human trial data that nattokinase has accumulated.
What Sets Japanese Nattokinase Research Apart
The NSK-SD Quality Standard
Most nattokinase guides mention that supplements come in varying quality — but few explain what quality actually means for an enzyme product. The Japan Nattokinase Association (JNKA) developed the NSK-SD certification mark, which verifies three critical parameters: vitamin K2 has been removed (essential for anticoagulant users), fibrinolytic activity is stable and accurately labeled in FU, and the product meets pharmaceutical-grade purity standards [19].
Why this matters: Without NSK-SD or equivalent verification, you have no guarantee that a nattokinase supplement actually contains the enzyme activity claimed on the label — or that it is free from vitamin K2, which could counteract the very cardiovascular benefit you are seeking.
A More Structured Regulatory Framework
In Japan, nattokinase products can receive functional food claims (機能性表示食品) through the Consumer Affairs Agency (消費者庁), allowing specific health benefit statements like "supports healthy blood pressure" and "promotes blood flow" [20]. Hundreds of nattokinase products have been registered with these claims. This regulatory framework requires submission of clinical evidence to support each claim — a more structured process than the United States, where supplements can be sold without pre-market review by the Food and Drug Administration (FDA).
Why this matters: The Japanese functional food system creates a layer of evidence review that gives consumers additional assurance about the specific benefits a product can claim. It is not a guarantee of efficacy, but it is a higher bar than many international markets require.
Japanese Manufacturing Technology
Japanese manufacturers have developed proprietary processes for nattokinase production that address specific quality challenges. These include technology for selectively removing vitamin K2 while preserving enzyme activity, achieving high FU concentrations (up to 20,000 FU per gram of raw material), and stability testing under various storage conditions [19].
Kobayashi Pharmaceutical (小林製薬), for example, produces nattokinase products with 10,000 FU activity and NSK-SD certification — representing some of the highest standardized potency available [22].
Why this matters: Enzyme supplements are inherently more sensitive to manufacturing conditions than simple vitamin or mineral products. The enzyme must remain biologically active through production, shipping, and storage. Japanese manufacturers with decades of experience in nattokinase production have refined these processes in ways that newer or less specialized manufacturers may not have matched.
Research Emphasis Differs Between Markets
English-language research on nattokinase is dominated by clinical outcome studies — randomized trials measuring blood pressure, lipid profiles, and atherosclerosis progression. Japanese research complements this with deeper focus on the enzyme's biochemistry, food science applications, optimal manufacturing conditions, and regulatory compliance [3].
Why this matters: Neither research tradition alone tells the complete story. English-language trials provide the clinical evidence for health benefits, while Japanese research provides the quality and manufacturing context that determines whether a given product can actually deliver those benefits. Reading both gives you a more complete picture than either alone.
Our Recommendations
Japanese Nattokinase 4000
Why We Selected This: From ORIHIRO, a Japanese manufacturer with extensive experience in enzyme supplements. This product delivers 4,000 FU of nattokinase per daily serving — meeting the upper range of clinically studied doses. It also includes DHA and EPA for complementary cardiovascular support. We chose it for customers who want a high-potency nattokinase option from a trusted Japanese manufacturer.
ORIHIRO has been producing health supplements in Japan for decades, with particular expertise in enzyme and fermented food-based products. Their nattokinase formulation reflects Japanese manufacturing standards for enzyme stability and activity verification.
View Japanese Nattokinase 4000 →
Nattokinase EX
Why We Selected This: From Kobayashi Pharmaceutical (小林製薬), one of Japan's most recognized pharmaceutical companies. Nattokinase EX features NSK-SD certified nattokinase with 10,000 FU activity per serving — one of the highest standardized potencies available. The NSK-SD certification ensures vitamin K2 removal, making it suitable for individuals on anticoagulant therapy (with medical approval). Kobayashi's pharmaceutical-grade quality control and decades of nattokinase research make this our recommendation for those prioritizing quality assurance and potency.
Noguchi Nattokinase HQ
Why We Selected This: From the Noguchi Medical Research Institute (NMRI), this premium nattokinase supplement is formulated for comprehensive circulation support. The Noguchi name carries weight in Japanese health research, and this product reflects their focus on evidence-based formulation. We recommend it for customers who value research-backed Japanese health science.
Product Comparison
| Product | Manufacturer | Best For | Key Feature |
|---|---|---|---|
| Japanese Nattokinase 4000 | ORIHIRO | High-potency daily use | 4,000 FU + DHA/EPA |
| Nattokinase EX | Kobayashi Pharmaceutical | Maximum quality assurance | NSK-SD certified, 10,000 FU |
| Noguchi Nattokinase HQ | Noguchi Medical Research Institute | Research-backed formulation | Premium circulation support |
Conclusion
Nattokinase is a well-characterized fibrinolytic enzyme with a specific and interesting mechanism — directly breaking down fibrin and activating the body's own clot-dissolving pathways. Its strongest clinical evidence supports a modest but significant reduction in blood pressure, backed by a meta-analysis of randomized controlled trials. Cardiovascular benefits beyond blood pressure are less clearly established, with the largest prevention trial showing no effect on atherosclerosis progression despite confirming long-term safety.
The practical takeaways: look for supplements dosed in FU (not mg), aim for 2,000-4,000 FU per day based on clinical evidence, and prioritize NSK-SD certified products for quality assurance. If you take blood-thinning medications, medical consultation is essential before starting nattokinase.
Nattokinase may be most valuable for health-conscious adults interested in cardiovascular support who are not currently on anticoagulant therapy — used as part of a broader strategy that includes diet, exercise, and regular medical monitoring. It is a supplement with genuine biological activity, but it works best as one component of cardiovascular health management, not a standalone solution.
This article is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new health regimen, especially if you have existing health conditions or take medications. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.
Frequently Asked Questions
- Nattokinase: a promising alternative in prevention and treatment of cardiovascular diseases
- Nattokinase supplementation and cardiovascular risk factors: a systematic review and meta-analysis of randomized controlled trials
- Recent advances in nattokinase-enriched fermented soybean foods: a review
- Effects of nattokinase on blood pressure: a randomized, controlled trial
- Consumption of nattokinase is associated with reduced blood pressure and von Willebrand factor
- Nattokinase as an adjuvant therapeutic strategy: a review of fibrinolytic, antithrombotic, anti-inflammatory, and antioxidant effects
- Comparative cardioprotective effectiveness: NOACs vs. Nattokinase
- Nattokinase atherothrombotic prevention study: a randomized controlled trial
- Data recorded in real life support the safety of nattokinase in patients with vascular diseases
- Hypolipidemic, antihypertensive, and antithrombotic effects of nattokinase combined with red yeast rice
- The effect of Nattokinase-Monascus supplements on dyslipidemia
- Research progress of nattokinase in reducing blood lipids
- Nattokinase — Memorial Sloan Kettering Cancer Center
- Nattokinase — WebMD Vitamins & Supplements
- Should You Add Nattokinase to Your Wellness Routine?
- Nattokinase benefits, dosage, and side effects
- Diverse origins of fibrinolytic enzymes: a comprehensive review
- Effect of Nattokinase on the Blood Flow Improvement in Healthy Subjects
- 日本ナットウキナーゼ協会 (JNKA)
